Association of genetic variants with myocardial infarction in Japanese individuals with chronic kidney disease

Thrombosis and Haemostasis

Volumn 101, Issue 5, 2009, Pages 963-968

  Fujimaki, Tetsuo ^a   Kato, Kimihiko ^a   Yoshida, Tetsuro ^b   Oguri, Mitsutoshi ^c   Watanabe, Sachiro ^d   Metoki, Norifumi ^e   Yoshida, Hidemi ^f   Satoh, Kei ^f   Aoyagi, Yukitoshi ^g   Nishigaki, Yutaka ^g   Tanaka, Masashi ^g   Nozawa, Yoshinori ^h   Kimura, Genjiro ⁱ   Yamada, Yoshiji ^j  

^a GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^b Inabe General Hospital   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^d GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^e Hirosaki Stroke Center   (Japan)

^f HIROSAKI UNIVERSITY   (Japan)

^g TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^h GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

ⁱ NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^j MIE UNIVERSITY   (Japan)

more..

Author keywords

Chronic kidney disease; Genetics; Myocardial infarction; Polymorphism

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 7; FATTY ACID BINDING PROTEIN 2; GAP JUNCTION PROTEIN; GAP JUNCTION PROTEIN ALPHA 5; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; F7 GENE; FEMALE; GENE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HSPA8 GENE; HUMAN; INFORMATION; JAPAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THBS2 GENE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHRONIC DISEASE; FACTOR VII; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 66149183004     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-11-0761     Document Type: Article

References (29)

1. Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002; 39: 1113-1119. (Pubitemid 34267412)
2. Mann JF, Gerstein HC, Pogue J, et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629-636. (Pubitemid 32322240)
3. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005; 16: 180-188.
4. Imai E, Horio M, Iseki K, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 2007; 11: 156-163. (Pubitemid 47012510)
5. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305. (Pubitemid 39268908)
6. Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663. (Pubitemid 38392981)
7. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295. (Pubitemid 39258422)
8. Yamada Y, Ichihara S, Nishida T. Molecular genetics of myocardial infarction. Genomic Med 2008; 2: 7-22.
9. Yamada Y, Matsuo H, Segawa T, et al. Assessment of genetic risk for myocardial infarction. Thromb Haemost 2006; 96: 220-227. (Pubitemid 44219392)
10. Imai E, Matsuo S, Makino H, et al. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods. Hypertens Res 2008; 31: 1101-1107.
11. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
12. Itoh Y, Mizuki N, Shimada T, et al. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 2005; 57: 717-729. (Pubitemid 41598618)
13. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approch to multiple testing. J Royal Stat Soc B 1995; 57: 289-300.
14. Sjoland JA, Sidelmann JJ, Brabrand M, et al. Fibrin clot structure in patients with end-stage renal disease. Thromb Haemost 2007; 98: 339-345. (Pubitemid 47250237)
15. McCullough PA. Cardiovascular disease in chronic kidney disease from a cardiologist's perspective. Curr Opin Nephrol Hypertens 2004; 13: 591-600. (Pubitemid 39506906)
16. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104: 365-372. (Pubitemid 32666962)
17. Meade TW, North WR, Chakrabarti R, et al. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; 1: 1050-1054. (Pubitemid 10097868)
18. Hahn MW, Rockman MV, Soranzo N, et al. Population genetic and phylogenetic evidence for positive selection on regulatory mutations at the factor VII locus in humans. Genetics 2004; 167: 867-877. (Pubitemid 38931871)
19. Iacoviello L, Di Castelnuovo A, De Knijff P, et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1998; 338: 79-85. (Pubitemid 28042270)
20. McCarthy JJ, Parker A, Salem R, et al. Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet 2004; 41: 334-341. (Pubitemid 38608515)
21. Nishihama K, Yamada Y, Matsuo H, et al. Association of gene polymorphisms with myocardial infarction in individuals with or without conventional coronary risk factors. Int J Mol Med 2007; 19: 129-141.
22. Lane A, Green F, Scarabin PY, et al. Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. Atherosclerosis 1996; 119: 119-127. (Pubitemid 126335750)
23. Doggen CJ, Manger Cats V, Bertina RM, et al. A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men. Thromb Haemost 1998; 80: 281-285. (Pubitemid 28393624)
24. Ye Z, Liu EH, Higgins JP, et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006; 367: 651-658. (Pubitemid 43289155)
25. Girelli D, Russo C, Ferraresi P, et al. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000; 343: 774-780.
26. Gelb BD, Zhang J, Cotter PD, et al. Physical mapping of the human connexin 40 (GJA5), flavin-containing monooxygenase 5, and natriuretic peptide receptor a genes on 1q21. Genomics 1997; 39: 409-411. (Pubitemid 27078710)
27. Makino A, Platoshyn O, Suarez J, et al. Downregulation of connexin40 is associated with coronary endothelial cell dysfunction in streptozotocin-induced diabetic mice. Am J Physiol Cell Physiol 2008; 295: C221-230. (Pubitemid 352755806)
28. Baier LJ, Sacchettini JC, Knowler WC, et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995; 95: 1281-1287.
29. Guettier JM, Georgopoulos A, Tsai MY, et al. Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population. J Clin Endocrinol Metab 2005; 90: 1705-1711. (Pubitemid 40464041)